(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Washington Marriott Wardman Park

Feb 27, 2014 7:00 AM - Feb 28, 2014 4:30 PM

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Marketing Pharmaceuticals 2014: Regulating Drug Marketing in the Ever-Changing Regulatory/Legal/Health Care Environment

Back to Agenda

Session 8 Breakout 3 - Communicating During the Pre-Approval Stages

Session Chair(s)

Michael Misocky, JD, RPh

Michael Misocky, JD, RPh

President

Misocky Consulting Group LLC, United States

This session will examine what can be done, and what poses risks, during the investigational/pre-approval stage of a new product. What precautions are needed in reaching out to patient groups and insurers/formulary committees? Are there any truly safe harbors?

Speaker(s)

Katie Graham, PharmD, MS

Medical Perspective

Katie Graham, PharmD, MS

McKoy Consulting, United States

Mary Sullivan

Mary Sullivan

Boehringer Ingelheim Pharmaceuticals, Inc., United States

Joy Liu, JD

Legal Perspective

Joy Liu, JD

Ropes and Gray, United States

Partner

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.